These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 163177)

  • 1. [Investigations on immunity against poliomyelitis (author's transl)].
    Haas R; Petersen EE; Neumann-Haefelin D; Doerr HW; Eggert E; Enders G; Firtzlaff R; Kuwert E; Lennartz H; Schmidt WA
    Dtsch Med Wochenschr; 1975 Jan; 100(1):3-8. PubMed ID: 163177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunity against poliomyelitis in the German Federal Republic (author's transl)].
    Doerr HW; Glück H; Esser I; Firtzlaff R; Koch I; Maass G; May G; Meier-Ewert H; Neumann-Haefelin D; Thraenhart O; Wecker I
    Dtsch Med Wochenschr; 1979 Jul; 104(30):1065-7. PubMed ID: 467253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Status of immunity against poliomyelitis. Polio serosurvey in 1993].
    Diedrich S; Schreier E
    Dtsch Med Wochenschr; 1995 Feb; 120(8):239-44. PubMed ID: 7867480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Unusual defective antibody reaction after polio vaccination (author's transl)].
    Henigst W; Klose P; Paulig R
    MMW Munch Med Wochenschr; 1975 Jan; 117(3):83-6. PubMed ID: 803613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Status of immunity against poliomyelitis in Germany].
    Maass G; Doerr HW
    Dtsch Med Wochenschr; 1986 Oct; 111(44):1670-6. PubMed ID: 3021426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2001 serological survey in the Czech Republic--poliomyelitis.
    Matyásová I; Rainetová P; Cástková J
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The status of immunity against poliomyelitis. The 5th cooperative study of the German Union to Control Viral Diseases, Inc].
    Maass G; Weber B; Doerr HW
    Dtsch Med Wochenschr; 1991 Sep; 116(39):1457-62. PubMed ID: 1655377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mali children antipoliomyelitic immunity before and after two oral immunizations against poliomyelitis (author's transl)].
    Fofana Y; Ehrengut W; Koch I; Allerdist H; Diallo D
    Med Trop (Mars); 1981; 41(2):151-5. PubMed ID: 7242300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [German Health survey 1997/98: immune status against poliomyelitis].
    Diedrich S; Claus H; Thierfelder W; Bellach BM; Schreier E
    Dtsch Med Wochenschr; 2000 May; 125(19):584-8. PubMed ID: 11320716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
    Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
    Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Poliomyelitis epidemic in a district of Freiburg i. Br. in autumn 1975 (author's transl)].
    Luthardt T; Helwig H; Neumann-Haefelin D; Steinitz H; Weineck B; Staudt F; Staudt R
    Dtsch Med Wochenschr; 1976 Sep; 101(37):1345-8. PubMed ID: 954590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum conversion rate following oral poliomyelitis immunization in Mali, Africa 1982].
    Ehrengut W; AgRhaly A; Koch I; Koumaré B; Simaga SY; Diallo D
    Monatsschr Kinderheilkd; 1984 Jan; 132(1):29-31. PubMed ID: 6321963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies.
    Pírez MC; Olivera I; Diabarboure H; Montano A; Barañano R; Badía F; Bonnet MC
    Vaccine; 2009 May; 27(20):2689-94. PubMed ID: 19428880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Poliomyelitis in the Federal Republic of Germany. A retrospective study of 1973 (author's transl)].
    Neumann-Haefelin D; Newmann-Haefelin C; Baumeister HG; Knocke KW; Petersen EE; Haas R
    Dtsch Med Wochenschr; 1974 Dec; 99(51):2597-602. PubMed ID: 4373221
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunity in the population of the Saarland after oral polio vaccination. II. Study on the antibody inauation of 57 orally vaccinated children in the age group of 1 to 6 years].
    Esser I; Keuth U; Wilhelmi J
    Offentl Gesundheitswes; 1971 Jan; 33(1):31-5. PubMed ID: 4250360
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunogenicity of oral poliomyelitis vaccine (OPV) against variants of wild poliovirus type 3.
    Böthig B; Danes L; Dittmann S
    Bull World Health Organ; 1990; 68(5):597-600. PubMed ID: 1963118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity of the Croatian population to poliomyelitis--a serosurvey.
    Borcić B; Kruzić V; Kaić B; Ljubin-Sternak S; Ljubicić M; Dobrovsak-Sourek V
    Acta Med Croatica; 1998; 52(4-5):229-33. PubMed ID: 9988903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
    Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
    Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.